Global mRNA Vaccines & Therapeutics Market Research Report 2015-2025
- HEY3830700
- 108 Pages
- April 2020
- Healthcare
The global mRNA Vaccines & Therapeutics market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Argos Therapeutics
AstraZeneca
Bayer
BioNTech
Boehringer Ingelheim
CRISPR Therapeutics
CureVac
eTheRNA immunotherapies
Ethris
GlaxoSmithKline Vaccines
In-Cell-Art
Intellia Therapeutics
Janssen
Kernal Biologics
MaxCyte
Moderna Therapeutics
Novartis
PhaseRx
Precision NanoSystems
RaNa Therapeutics
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospital
Clinic
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure mRNA Vaccines & Therapeutics Picture
1.1.2 Specifications
Table Product Specifications of mRNA Vaccines & Therapeutics
1.2 Market Segment
1.2.1 by Type
Table Products Segment of mRNA Vaccines & Therapeutics
Table Global mRNA Vaccines & Therapeutics Market by Type, 2011-2022 (USD Million)
1.2.1.1 Standardization Of Cancer Treatment MRNA Vaccine
Table Standardization Of Cancer Treatment MRNA Vaccine Overview
1.2.1.2 Individualized Cancer Treatment MRNA Vaccine
Table Individualized Cancer Treatment MRNA Vaccine Overview
1.2.1.3 Infectious Disease Treatment MRNA Vaccine
Table Infectious Disease Treatment MRNA Vaccine Overview
1.2.1.4 Infection Prevention MRNA Vaccine
Table Infection Prevention MRNA Vaccine Overview
1.2.2 by Application
Table Application Segment of mRNA Vaccines & Therapeutics
Table Global mRNA Vaccines & Therapeutics Market by Application, 2011-2022 (USD Million)
1.2.2.1 Hospital
Table Hospital Overview
1.2.2.2 Clinic
Table Clinic Overview
1.2.2.3 Others
Table Others Overview
1.2.3 by Regions
Table Global mRNA Vaccines & Therapeutics Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of mRNA Vaccines & Therapeutics
2.2 Upstream
Table Cost of mRNA Vaccines & Therapeutics
Figure Manufacturing Process of mRNA Vaccines & Therapeutics
2.3 Market
2.3.1 SWOT
Figure SWOT of mRNA Vaccines & Therapeutics
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of mRNA Vaccines & Therapeutics
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of mRNA Vaccines & Therapeutics
3.4 Market Entry
Table Market Entry of mRNA Vaccines & Therapeutics
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Standardization Of Cancer Treatment MRNA Vaccine Market, 2013-2018
Figure Standardization Of Cancer Treatment MRNA Vaccine Market Size and Growth, 2015-2019 (USD Million)
Figure Standardization Of Cancer Treatment MRNA Vaccine Market Size and Growth, 2015-2019 (in Volume)
Table Standardization Of Cancer Treatment MRNA Vaccine CAGR by Revenue and Volume, 2015-2019
4.1.2 Individualized Cancer Treatment MRNA Vaccine Market, 2013-2018
Figure Individualized Cancer Treatment MRNA Vaccine Market Size and Growth, 2015-2019 (USD Million)
Figure Individualized Cancer Treatment MRNA Vaccine Market Size and Growth, 2015-2019 (in Volume)
Table Individualized Cancer Treatment MRNA Vaccine CAGR by Revenue and Volume, 2015-2019
4.1.3 Infectious Disease Treatment MRNA Vaccine Market, 2013-2018
Figure Infectious Disease Treatment MRNA Vaccine Market Size and Growth, 2015-2019 (USD Million)
Figure Infectious Disease Treatment MRNA Vaccine Market Size and Growth, 2015-2019 (in Volume)
Table Infectious Disease Treatment MRNA Vaccine CAGR by Revenue and Volume, 2015-2019
4.1.4 Infection Prevention MRNA Vaccine Market, 2013-2018
Figure Infection Prevention MRNA Vaccine Market Size and Growth, 2015-2019 (USD Million)
Figure Infection Prevention MRNA Vaccine Market Size and Growth, 2015-2019 (in Volume)
Table Infection Prevention MRNA Vaccine CAGR by Revenue and Volume, 2015-2019
4.2 Market Forecast
4.2.1 Standardization Of Cancer Treatment MRNA Vaccine Market Forecast, 2020-2025
Figure Standardization Of Cancer Treatment MRNA Vaccine Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Standardization Of Cancer Treatment MRNA Vaccine Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Standardization Of Cancer Treatment MRNA Vaccine CAGR by Revenue and Volume, 2012-2024
4.2.2 Individualized Cancer Treatment MRNA Vaccine Market Forecast, 2020-2025
Figure Individualized Cancer Treatment MRNA Vaccine Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Individualized Cancer Treatment MRNA Vaccine Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Individualized Cancer Treatment MRNA Vaccine CAGR by Revenue and Volume, 2012-2024
4.2.3 Infectious Disease Treatment MRNA Vaccine Market Forecast, 2020-2025
Figure Infectious Disease Treatment MRNA Vaccine Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Infectious Disease Treatment MRNA Vaccine Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Infectious Disease Treatment MRNA Vaccine CAGR by Revenue and Volume, 2012-2024
4.2.4 Infection Prevention MRNA Vaccine Market Forecast, 2020-2025
Figure Infection Prevention MRNA Vaccine Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Infection Prevention MRNA Vaccine Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Infection Prevention MRNA Vaccine CAGR by Revenue and Volume, 2012-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Hospital Market, 2013-2018
Figure Hospital Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Hospital CAGR by Revenue and Volume, 2015-2019
5.1.2 Clinic Market, 2013-2018
Figure Clinic Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Clinic CAGR by Revenue and Volume, 2015-2019
5.1.3 Others Market, 2013-2018
Figure Others Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Others CAGR by Revenue and Volume, 2015-2019
5.2 Market Forecast
5.2.1 Hospital Market Forecast, 2020-2025
Figure Hospital Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Hospital Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Hospital CAGR by Revenue and Volume, 2020-2025
5.2.2 Clinic Market Forecast, 2020-2025
Figure Clinic Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Clinic Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Clinic CAGR by Revenue and Volume, 2020-2025
5.2.3 Others Market Forecast, 2020-2025
Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Others CAGR by Revenue and Volume, 2020-2025
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2015-2019
Figure Asia-Pacific Market Size and Growth, 2015-2019 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2015-2019 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2015-2019
Figure North America Market Size and Growth, 2015-2019 (USD Million)
Figure North America Market Size and Growth, 2015-2019 (in Volume)
Table North America CAGR by Revenue and Volume, 2015-2019
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2015-2019
Figure Europe Market Size and Growth, 2015-2019 (USD Million)
Figure Europe Market Size and Growth, 2015-2019 (in Volume)
Table Europe CAGR by Revenue and Volume, 2015-2019
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2015-2019
Figure South America Market Size and Growth, 2015-2019 (USD Million)
Figure South America Market Size and Growth, 2015-2019 (in Volume)
Table South America CAGR by Revenue and Volume, 2015-2019
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2015-2019
Figure Middle East & Africa Market Size and Growth, 2015-2019 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2015-2019 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2020-2025
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
6.2.2 North America Market Forecast, 2020-2025
Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table North America CAGR by Revenue and Volume, 2020-2025
6.2.3 Europe Market Forecast, 2020-2025
Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Europe CAGR by Revenue and Volume, 2020-2025
6.2.4 South America Market Forecast, 2020-2025
Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table South America CAGR by Revenue and Volume, 2020-2025
6.2.5 Middle East & Africa Market Forecast, 2020-2025
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
7 Market Competitive
7.1 Global Market by Vendors
Table Global mRNA Vaccines & Therapeutics Market by Vendors, 2015-2019 (in Volume)
Table Global mRNA Vaccines & Therapeutics Market Share by Vendors, 2015-2019 (USD Million)
Table Global mRNA Vaccines & Therapeutics Market Share by Vendors, 2015-2019 (in Volume)
7.2 Market Concentration
Figure mRNA Vaccines & Therapeutics Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Argos Therapeutics
Table Argos Therapeutics Profile List
Table Microecological Modulator Operating Data of Argos Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 AstraZeneca
Table AstraZeneca Profile List
Table Microecological Modulator Operating Data of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Bayer
Table Bayer Profile List
Table Microecological Modulator Operating Data of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 BioNTech
Table BioNTech Profile List
Table Microecological Modulator Operating Data of BioNTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Boehringer Ingelheim
Table Boehringer Ingelheim Profile List
Table Microecological Modulator Operating Data of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 CRISPR Therapeutics
Table CRISPR Therapeutics Profile List
Table Microecological Modulator Operating Data of CRISPR Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 CureVac
Table CureVac Profile List
Table Microecological Modulator Operating Data of CureVac (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 eTheRNA immunotherapies
Table eTheRNA immunotherapies Profile List
Table Microecological Modulator Operating Data of eTheRNA immunotherapies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 Ethris
Table Ethris Profile List
Table Microecological Modulator Operating Data of Ethris (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 GlaxoSmithKline Vaccines
Table GlaxoSmithKline Vaccines Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline Vaccines (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.11 In-Cell-Art
Table In-Cell-Art Profile List
Table Microecological Modulator Operating Data of In-Cell-Art (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.12 Intellia Therapeutics
Table Intellia Therapeutics Profile List
Table Microecological Modulator Operating Data of Intellia Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.13 Janssen
Table Janssen Profile List
Table Microecological Modulator Operating Data of Janssen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.14 Kernal Biologics
Table Kernal Biologics Profile List
Table Microecological Modulator Operating Data of Kernal Biologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.15 MaxCyte
Table MaxCyte Profile List
Table Microecological Modulator Operating Data of MaxCyte (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.16 Moderna Therapeutics
Table Moderna Therapeutics Profile List
Table Microecological Modulator Operating Data of Moderna Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.17 Novartis
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.18 PhaseRx
Table PhaseRx Profile List
Table Microecological Modulator Operating Data of PhaseRx (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.19 Precision NanoSystems
Table Precision NanoSystems Profile List
Table Microecological Modulator Operating Data of Precision NanoSystems (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.20 RaNa Therapeutics
Table RaNa Therapeutics Profile List
Table Microecological Modulator Operating Data of RaNa Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Table Product Specifications of mRNA Vaccines & Therapeutics
Table Products Segment of mRNA Vaccines & Therapeutics
Table Global mRNA Vaccines & Therapeutics Market by Type, 2011-2022 (USD Million)
Table Standardization Of Cancer Treatment MRNA Vaccine Overview
Table Individualized Cancer Treatment MRNA Vaccine Overview
Table Infectious Disease Treatment MRNA Vaccine Overview
Table Infection Prevention MRNA Vaccine Overview
Table Application Segment of mRNA Vaccines & Therapeutics
Table Global mRNA Vaccines & Therapeutics Market by Application, 2011-2022 (USD Million)
Table Hospital Overview
Table Clinic Overview
Table Others Overview
Table Global mRNA Vaccines & Therapeutics Market by Region, 2011-2022 (USD Million)
Table Cost of mRNA Vaccines & Therapeutics
Table Market Dynamics
Table Policy of mRNA Vaccines & Therapeutics
Table GDP of Major Countries
Table Technology of mRNA Vaccines & Therapeutics
Table Market Entry of mRNA Vaccines & Therapeutics
Table Standardization Of Cancer Treatment MRNA Vaccine CAGR by Revenue and Volume, 2015-2019
Table Individualized Cancer Treatment MRNA Vaccine CAGR by Revenue and Volume, 2015-2019
Table Infectious Disease Treatment MRNA Vaccine CAGR by Revenue and Volume, 2015-2019
Table Infection Prevention MRNA Vaccine CAGR by Revenue and Volume, 2015-2019
Table Standardization Of Cancer Treatment MRNA Vaccine CAGR by Revenue and Volume, 2012-2024
Table Individualized Cancer Treatment MRNA Vaccine CAGR by Revenue and Volume, 2012-2024
Table Infectious Disease Treatment MRNA Vaccine CAGR by Revenue and Volume, 2012-2024
Table Infection Prevention MRNA Vaccine CAGR by Revenue and Volume, 2012-2024
Table Hospital CAGR by Revenue and Volume, 2015-2019
Table Clinic CAGR by Revenue and Volume, 2015-2019
Table Others CAGR by Revenue and Volume, 2015-2019
Table Hospital CAGR by Revenue and Volume, 2020-2025
Table Clinic CAGR by Revenue and Volume, 2020-2025
Table Others CAGR by Revenue and Volume, 2020-2025
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
Table North America CAGR by Revenue and Volume, 2015-2019
Table Europe CAGR by Revenue and Volume, 2015-2019
Table South America CAGR by Revenue and Volume, 2015-2019
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
Table North America CAGR by Revenue and Volume, 2020-2025
Table Europe CAGR by Revenue and Volume, 2020-2025
Table South America CAGR by Revenue and Volume, 2020-2025
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
Table Global mRNA Vaccines & Therapeutics Market by Vendors, 2015-2019 (in Volume)
Table Global mRNA Vaccines & Therapeutics Market Share by Vendors, 2015-2019 (USD Million)
Table Global mRNA Vaccines & Therapeutics Market Share by Vendors, 2015-2019 (in Volume)
Table Price Factors List
Table Argos Therapeutics Profile List
Table Microecological Modulator Operating Data of Argos Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Profile List
Table Microecological Modulator Operating Data of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer Profile List
Table Microecological Modulator Operating Data of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BioNTech Profile List
Table Microecological Modulator Operating Data of BioNTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Profile List
Table Microecological Modulator Operating Data of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CRISPR Therapeutics Profile List
Table Microecological Modulator Operating Data of CRISPR Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CureVac Profile List
Table Microecological Modulator Operating Data of CureVac (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table eTheRNA immunotherapies Profile List
Table Microecological Modulator Operating Data of eTheRNA immunotherapies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ethris Profile List
Table Microecological Modulator Operating Data of Ethris (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Vaccines Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline Vaccines (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table In-Cell-Art Profile List
Table Microecological Modulator Operating Data of In-Cell-Art (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Intellia Therapeutics Profile List
Table Microecological Modulator Operating Data of Intellia Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Janssen Profile List
Table Microecological Modulator Operating Data of Janssen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kernal Biologics Profile List
Table Microecological Modulator Operating Data of Kernal Biologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MaxCyte Profile List
Table Microecological Modulator Operating Data of MaxCyte (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Moderna Therapeutics Profile List
Table Microecological Modulator Operating Data of Moderna Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table PhaseRx Profile List
Table Microecological Modulator Operating Data of PhaseRx (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Precision NanoSystems Profile List
Table Microecological Modulator Operating Data of Precision NanoSystems (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table RaNa Therapeutics Profile List
Table Microecological Modulator Operating Data of RaNa Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
